目的 构建血管紧张素转换酶2(ACE2)的复制缺陷重组腺病毒AdACE2,并观察其对载脂蛋白E基因敲除(ApoE^-/-)小鼠动脉硬化黏附分子的影响及意义。方法 采用RTPCR反应,从小鼠肾脏组织中扩增出小鼠ACE2基因全长的cDNA序列,克隆到pMD18T载体,之后再亚克隆到pDC316载体,构建穿梭质粒(pDC316ACE2)。穿梭质粒与腺病毒骨架质粒进行同源重组,形成重组腺病毒质粒,重组腺病毒质粒在293细胞内包装成为复制缺陷重组腺病毒AdACE2。采用高脂饲养建立动脉粥样硬化模型后,将16只ApoE^-/-小鼠随机分为ACE2基因治疗组和ACE2基因对照组,每组8只。通过尾静脉注射AdACE2和AdEGFP分别干预,采用油红O染色,免疫组化及Westernblotting观察ACE2治疗后斑块的脂质含量,血管细胞黏附分子(VCAM1)及E选择素的变化。结果 聚合酶链式反应(PCR)、酶切及测序结果证实,AdACE2构建成功;ACE2基因治疗组动脉硬化斑块内脂质含量和黏附分子的表达低于ACE2基因对照组。结论 AdACE2构建成功;ACE2基因过表达可降低动脉粥样硬化斑块内的脂质含量、VCAM1和E选择素的表达,减轻斑块严重程度。
Objective To construct replication-deficient recombinant adenovirus Ad-ACE2 and to investigate the effects of angiotensin-converting enzyme 2 (ACE2) on the severity of atherosclerosis in apolipoprotein-E knockout (ApoE^-/-) mice. Methods The full-length ACE2 encoding sequence was amplified from the RNA of mice kidney tissue by RT-PCR technique, cloned into plasmid pMD18-T vector, and then subcloned into plasmid pDC316 to form pDC316-ACE2. Homologous recombination was conducted between the shuttle plasmid and adenovirus skeleton plasmid to form recombinant adenovirus plasmid, then recombinant adenovirus plasmid was packed into replication-deficient recombinant adenovirus (Ad-ACE2) in the 293 cell. High-fat feeding was applied to establish 16 mice models of ather- osclerosis, which were then divided into two groups randomly, receiving Ad-ACE2 and Ad-EGFP tail vein injection respectively. The lipid contents, protein expressions of vascular cell adhesion molecule-1 ( VCAM-1 ) and E-selectin were evaluated by Oil Red O staining, immunohistochemical method and Western blotting. Results The recombinant plasmid Ad-ACE2 was confirmed by polymerase chain reaction, enzyme digesting and DNA sequencing. The lipid con- tents, protein expressions of VCAM-1 and E-selectin were significantly lower in ACE2 gene treatment group than in ACE2 gene control group. Conclusion Ad-ACE2 is constructed successfully. Overexpression of ACE2 gene can reduce the lipid contents and protein expressions of VCAM-1 and E-selectin in the atherosclerotic plaque, and alleviate the severity of atherosclerotic plaque in ApoE ^-/- mice.